title: [Current aspects in epistaxis].
abstract: A survey of current literature on the topic of epistaxis revealed only a circumscript number of publications with a high methodologic value. The analysis of these publications showed that there is a controversy on the necessity of routine coagulation tests in epistaxis patients. These tests should only be performed in cases with clinical evidence of a coagulation disorder. Also, there is an ongoing controversy on the value of local cooling with ice or cold packs. Nasal creams and decongestive nose drops have been found to be effective in uncomplicated epistaxis. Rhinoscopically and endoscopically targeted coagulation of bleeding vessels and nasal packing are recommended treatment options. There is a debate on discontinuation of anticoagulant therapy, if INR is within normal limits in Cumadin patients. Intractable epistaxis requires a broad armamentarium of different diagnostic and therapeutic options. Recurrent epistaxis in hereditary syndromes remains to be a challenge, although some advances have been made in diagnosis and symptomatic treatment. Some new medical drugs, as Viagra or Cialis may have nosebleeds as side-effects.
authors.affiliation: Klinik für Hals-, Nasen- und Ohrenheilkunde, Karl Hansen Klinik, Antoniusstrasse 19, 33175 Bad Lippspringe, Deutschland. b.j.folz@medizinisches-zentrum.de
authors.forename: B J
authors.initials: BJ
authors.lastname: Folz
authors.forename: M
authors.initials: M
authors.lastname: Kanne
authors.forename: J A
authors.initials: JA
authors.lastname: Werner
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001780:Blood Coagulation Tests / Q000639:trends*; D004621:Embolization, Therapeutic / Q000639:trends*; D004844:Epistaxis / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007036:Hypothermia, Induced / Q000639:trends*
chemical_list: D000925:Anticoagulants